DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ. CANTOS Trial Group.
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
Lancet 2017;
390 (10105): 1833-1842
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.